2006•Sichuan Mental HealthRequires access

A controlled analysis of the efficacy between aripiprazole and risperidone in the treatment of patients with schizophrenia.

Zhong Ku

Abstract

Objective To analyse efficacy and side effect of aripiprazole in the treatment of patients with schizophrenia.Methods 80 patients of schizophrenia were divided into aripiprazole group and risperidone group for the treatment of 6 weeks.The efficacy and side effect were evaluated with PANSS,CGI-SI and TESS respectively.Results There were no significantly differences of the efficacy between aripiprazole group and risperidone group in the treatment of the patients with schizophrenia.The side effects of aripiprazole were slighter and fewer than that of risperidone group.Conclusion Aripiprazole has an efficacy obiously in improving to the symptoms of patients with schizophrenia.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Side effect (computer science), Medicine, Psychology, Internal medicine, Clinical efficacy